407 related articles for article (PubMed ID: 24758141)
1. pH triggered delivery of curcumin from Eudragit-coated chitosan microspheres for inflammatory bowel disease: characterization and pharmacodynamic evaluation.
Sareen R; Jain N; Rajkumari A; Dhar KL
Drug Deliv; 2016; 23(1):55-62. PubMed ID: 24758141
[TBL] [Abstract][Full Text] [Related]
2. Carboxymethyl chitosan microspheres loaded hyaluronic acid/gelatin hydrogels for controlled drug delivery and the treatment of inflammatory bowel disease.
Zhang S; Kang L; Hu S; Hu J; Fu Y; Hu Y; Yang X
Int J Biol Macromol; 2021 Jan; 167():1598-1612. PubMed ID: 33220374
[TBL] [Abstract][Full Text] [Related]
3. Development of colon specific microspheres of flurbiprofen for inflammatory bowel disease.
Sareen R; Jain N; Dhar KL
Curr Drug Deliv; 2013 Oct; 10(5):564-71. PubMed ID: 23360241
[TBL] [Abstract][Full Text] [Related]
4. Development and evaluation of a novel phytosome-loaded chitosan microsphere system for curcumin delivery.
Zhang J; Tang Q; Xu X; Li N
Int J Pharm; 2013 May; 448(1):168-74. PubMed ID: 23524117
[TBL] [Abstract][Full Text] [Related]
5. Formulation and evaluation of chitosan microspheres of aceclofenac for colon-targeted drug delivery.
Umadevi SK; Thiruganesh R; Suresh S; Reddy KB
Biopharm Drug Dispos; 2010 Oct; 31(7):407-27. PubMed ID: 20848388
[TBL] [Abstract][Full Text] [Related]
6. Colon targeted curcumin microspheres laden with ascorbic acid for bioavailability enhancement.
Karade PG; Jadhav NR
J Microencapsul; 2018 Jun; 35(4):372-380. PubMed ID: 30010458
[TBL] [Abstract][Full Text] [Related]
7. Mucoadhesive microparticulates based on polysaccharide for target dual drug delivery of 5-aminosalicylic acid and curcumin to inflamed colon.
Duan H; Lü S; Gao C; Bai X; Qin H; Wei Y; Wu X; Liu M
Colloids Surf B Biointerfaces; 2016 Sep; 145():510-519. PubMed ID: 27239905
[TBL] [Abstract][Full Text] [Related]
8. Design and development of multiparticulate system for targeted drug delivery to colon.
Chourasia MK; Jain SK
Drug Deliv; 2004; 11(3):201-7. PubMed ID: 15204639
[TBL] [Abstract][Full Text] [Related]
9. Development and characterization of colon specific drug delivery system bearing 5-ASA and Camylofine dihydrochloride for the treatment of ulcerative colitis.
Dubey R; Dubey R; Omrey P; Vyas SP; Jain SK
J Drug Target; 2010 Sep; 18(8):589-601. PubMed ID: 20088681
[TBL] [Abstract][Full Text] [Related]
10. Colon specific chitosan microspheres for chronotherapy of chronic stable angina.
Jose S; Prema MT; Chacko AJ; Thomas AC; Souto EB
Colloids Surf B Biointerfaces; 2011 Apr; 83(2):277-83. PubMed ID: 21194900
[TBL] [Abstract][Full Text] [Related]
11. Development of Chitosan-Based pH-Sensitive Polymeric Micelles Containing Curcumin for Colon-Targeted Drug Delivery.
Woraphatphadung T; Sajomsang W; Rojanarata T; Ngawhirunpat T; Tonglairoum P; Opanasopit P
AAPS PharmSciTech; 2018 Apr; 19(3):991-1000. PubMed ID: 29110292
[TBL] [Abstract][Full Text] [Related]
12. Eudragit S-100 coated sodium alginate microspheres of naproxen sodium: formulation, optimization and in vitro evaluation.
Chawla A; Sharma P; Pawar P
Acta Pharm; 2012 Dec; 62(4):529-45. PubMed ID: 23333888
[TBL] [Abstract][Full Text] [Related]
13. Comparison of simple Eudragit microparticles loaded with prednisolone and Eudragit-coated chitosan-succinyl-prednisolone conjugate microparticles: Part I. Particle characteristics and in vitro evaluation as a colonic delivery system.
Onishi H; Kikuchi H; Machida Y
Drug Dev Ind Pharm; 2012 Jul; 38(7):800-7. PubMed ID: 22077373
[TBL] [Abstract][Full Text] [Related]
14. Curcumin loaded microsponges for colon targeting in inflammatory bowel disease: fabrication, optimization, and in vitro and pharmacodynamic evaluation.
Sareen R; Nath K; Jain N; Dhar KL
Biomed Res Int; 2014; 2014():340701. PubMed ID: 25093165
[TBL] [Abstract][Full Text] [Related]
15. Eudragit-coated aceclofenac-loaded pectin microspheres in chronopharmacological treatment of rheumatoid arthritis.
Ramasamy T; Ruttala HB; Shanmugam S; Umadevi SK
Drug Deliv; 2013 Feb; 20(2):65-77. PubMed ID: 23537465
[TBL] [Abstract][Full Text] [Related]
16. QbD-Enabled Systematic Development of Ileo-Colonic Targeted Novel Mucoadhesive Microspheres of Flurbiprofen.
Pande S; Vashi J; Solanki A
Curr Drug Deliv; 2022; 19(3):407-419. PubMed ID: 34238189
[TBL] [Abstract][Full Text] [Related]
17. Eudragit-coated dextran microspheres of 5-fluorouracil for site-specific delivery to colon.
Rai G; Yadav AK; Jain NK; Agrawal GP
Drug Deliv; 2016; 23(1):328-37. PubMed ID: 24845476
[TBL] [Abstract][Full Text] [Related]
18. Preparation, characterization, pharmacokinetics, and tissue distribution of curcumin nanosuspension with TPGS as stabilizer.
Gao Y; Li Z; Sun M; Li H; Guo C; Cui J; Li A; Cao F; Xi Y; Lou H; Zhai G
Drug Dev Ind Pharm; 2010 Oct; 36(10):1225-34. PubMed ID: 20545506
[TBL] [Abstract][Full Text] [Related]
19. Novel formulation of solid lipid microparticles of curcumin for anti-angiogenic and anti-inflammatory activity for optimization of therapy of inflammatory bowel disease.
Yadav VR; Suresh S; Devi K; Yadav S
J Pharm Pharmacol; 2009 Mar; 61(3):311-21. PubMed ID: 19222903
[TBL] [Abstract][Full Text] [Related]
20. Development and optimization of curcumin-loaded mannosylated chitosan nanoparticles using response surface methodology in the treatment of visceral leishmaniasis.
Chaubey P; Patel RR; Mishra B
Expert Opin Drug Deliv; 2014 Aug; 11(8):1163-81. PubMed ID: 24875148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
